Assembly Bio prices $175M equity financing; net proceeds ~$167M

ASSEMBLY BIOSCIENCES, INC.

Underwritten offering: 5.6M shares + 1.04M pre-funded warrants at $19.60/unit; net ~$122M.
Gilead purchases 2.3M shares + warrants in private placement at same price; net ~$45M.
Class A warrants exercisable at $21.60, expire 5 years from issuance or 30 days after Phase 2 enrollment announcement.
Class B warrants exercisable after Nov 15, 2026 until Dec 31, 2026; terminate early if $75M non-dilutive collaboration capital received.
Proceeds for general corporate purposes; closings on August 11, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.